Initial delivery of an order for 600 LabPad® Evolution to German distributor IMACO.
On January 8th, 2021, AVALUN delivered a first batch of its newly launched LabPad® Evolution product to its German partner IMACO. With a first order of 600 LabPad® Evolution placed last November, IMACO’s objective is to offer German’s healthcare professional an enhanced solution to help them respond to the COVID-19 pandemic.
About the LabPad® Evolution
LabPad® Evolution is a handheld Point of Care (PoC) multi-measurements testing device, designed to assist healthcare professionals in direct contact with patients, wherever they are. It operates with a range of compatible single-use tests, each test allowing for the performance of a specific biology test. Currently available tests are for SARS-COV2 Antigen and TP/INR rapid tests. A serologic test for SARS-COV2 will follow in Q1, 2021. Next tests to be made available will then be for nutrition and cardiac markers.
For any inquiries, please contact us via e-mail email@example.com